2025 Q3 -tulosraportti
Vain PDF
81 päivää sitten
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
100
Myynti
Määrä
9 494
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 93 | - | - | ||
| 5 | - | - | ||
| 2 | - | - | ||
| 7 970 | - | - | ||
| 3 717 | - | - |
Ylin
0,29VWAP
Alin
0,268VaihtoMäärä
0,5 1 925 610
VWAP
Ylin
0,29Alin
0,268VaihtoMäärä
0,5 1 925 610
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 925 610 | 1 925 610 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 925 610 | 1 925 610 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 13.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 14.11.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2025 Q1 -tulosraportti | 30.4.2025 | |
| 2024 Q4 -tulosraportti | 14.2.2025 | |
| 2024 Q3 -tulosraportti | 15.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·29.1.The share price is ridiculously low. Ibindex calculates the net asset value discount at 93 %. But in reality, it is much higher. In fact, when you deduct the liquid assets and the small listed share in the portfolio, you get all the unlisted shares completely free and more. Since this catastrophic emission failed (only 21 - 23 % was sold at full price - and only 34 % with a discount), the price of the old ordinary share, now that we know the dilution from the emission, should not be as low as 0.28 at all. The share - which had already fallen sharply - cost 0.63 SEK on the last trading day in November. With the dilution that has now occurred, where the emission was only completed by 57 %, the new price of the ordinary share (and the BTA) should theoretically immediately after the announcement rise to approx. 0.41 SEK, to correspond to the price before the emission. But things always go wrong with emissions in biotech - and this one showed from the start the epitome of incompetent management - unfortunately. But right now, you get all the shares for free if you pay 0.28 SEK, which roughly corresponds to the cash balance. Incredible - but true. And incredible that the main shareholder did not participate in the emission, but merely let their investment be diluted in this foolish way.
2 päivää sitten2 päivää sittenThey have little chance to ever make profit on paper because the valuations on the balance sheet are astronomical, let alone finding anyone to buy any of the unlisted assets above the current valuations. You can't even value the cash at cash, because it's going to the investments, like you said, and the investment decisions are conducted by unbelievably incompetent people who are going to destroy capital as long as there is enough stupid people to further fund the company.·1 päivä sittenWith this premise " the investment decisions are conducted by unbelievably incompetent people who are going to destroy capital as long as there is enough stupid people to further fund the company." it is clear that you set the value of cash to 0 kr. in the long term. That is essentially also what I write in my analysis, namely that one must of course assess whether one believes in the company's management.
·28.1.The result of the issue may come tomorrow. The situation is unstable now and not all BTAs are out yet. It could go either way. BTA from subscription without TR is not finalized. Are there many of them? I note, however, that the turnover is relatively low compared to Medivir.
·27.1. · MuokattuNo matter how much this stock goes down, it always seems like there's 100 % left to go down...
·28.1.That applies to all stocks, for that matter :)
·28.1.The main owner seems not to have subscribed (at least not much, as a total of 21% was subscribed with subscription rights), so it will be very interesting to see the new ownership structure when the dust has settled after some guarantors' sell-off. Hope Anders Hallberg steps in significantly and sorts this out now.- ·27.1.The underwriters have received a nice discount, since they are now selling 10% below the price we others have paid. There is currently a large hidden block BTA at a price of 2.7.·27.1.Yes, it seems IngvarS was right here. I interpret the trading in BTA to mean that guarantors have received allocation and then guess that the subscription rate will end up at the guarantee level and then KD gets in approx 100M and that makes a total of approx 650M shares (270+380) which gives a market cap of 175M at 0.27
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
Vain PDF
81 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·29.1.The share price is ridiculously low. Ibindex calculates the net asset value discount at 93 %. But in reality, it is much higher. In fact, when you deduct the liquid assets and the small listed share in the portfolio, you get all the unlisted shares completely free and more. Since this catastrophic emission failed (only 21 - 23 % was sold at full price - and only 34 % with a discount), the price of the old ordinary share, now that we know the dilution from the emission, should not be as low as 0.28 at all. The share - which had already fallen sharply - cost 0.63 SEK on the last trading day in November. With the dilution that has now occurred, where the emission was only completed by 57 %, the new price of the ordinary share (and the BTA) should theoretically immediately after the announcement rise to approx. 0.41 SEK, to correspond to the price before the emission. But things always go wrong with emissions in biotech - and this one showed from the start the epitome of incompetent management - unfortunately. But right now, you get all the shares for free if you pay 0.28 SEK, which roughly corresponds to the cash balance. Incredible - but true. And incredible that the main shareholder did not participate in the emission, but merely let their investment be diluted in this foolish way.2 päivää sitten2 päivää sittenThey have little chance to ever make profit on paper because the valuations on the balance sheet are astronomical, let alone finding anyone to buy any of the unlisted assets above the current valuations. You can't even value the cash at cash, because it's going to the investments, like you said, and the investment decisions are conducted by unbelievably incompetent people who are going to destroy capital as long as there is enough stupid people to further fund the company.·1 päivä sittenWith this premise " the investment decisions are conducted by unbelievably incompetent people who are going to destroy capital as long as there is enough stupid people to further fund the company." it is clear that you set the value of cash to 0 kr. in the long term. That is essentially also what I write in my analysis, namely that one must of course assess whether one believes in the company's management.
- ·28.1.The result of the issue may come tomorrow. The situation is unstable now and not all BTAs are out yet. It could go either way. BTA from subscription without TR is not finalized. Are there many of them? I note, however, that the turnover is relatively low compared to Medivir.
- ·27.1. · MuokattuNo matter how much this stock goes down, it always seems like there's 100 % left to go down...·28.1.That applies to all stocks, for that matter :)·28.1.The main owner seems not to have subscribed (at least not much, as a total of 21% was subscribed with subscription rights), so it will be very interesting to see the new ownership structure when the dust has settled after some guarantors' sell-off. Hope Anders Hallberg steps in significantly and sorts this out now.
- ·27.1.The underwriters have received a nice discount, since they are now selling 10% below the price we others have paid. There is currently a large hidden block BTA at a price of 2.7.·27.1.Yes, it seems IngvarS was right here. I interpret the trading in BTA to mean that guarantors have received allocation and then guess that the subscription rate will end up at the guarantee level and then KD gets in approx 100M and that makes a total of approx 650M shares (270+380) which gives a market cap of 175M at 0.27
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
100
Myynti
Määrä
9 494
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 93 | - | - | ||
| 5 | - | - | ||
| 2 | - | - | ||
| 7 970 | - | - | ||
| 3 717 | - | - |
Ylin
0,29VWAP
Alin
0,268VaihtoMäärä
0,5 1 925 610
VWAP
Ylin
0,29Alin
0,268VaihtoMäärä
0,5 1 925 610
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 925 610 | 1 925 610 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 925 610 | 1 925 610 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 13.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 14.11.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2025 Q1 -tulosraportti | 30.4.2025 | |
| 2024 Q4 -tulosraportti | 14.2.2025 | |
| 2024 Q3 -tulosraportti | 15.11.2024 |
2025 Q3 -tulosraportti
Vain PDF
81 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 13.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 14.11.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2025 Q1 -tulosraportti | 30.4.2025 | |
| 2024 Q4 -tulosraportti | 14.2.2025 | |
| 2024 Q3 -tulosraportti | 15.11.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·29.1.The share price is ridiculously low. Ibindex calculates the net asset value discount at 93 %. But in reality, it is much higher. In fact, when you deduct the liquid assets and the small listed share in the portfolio, you get all the unlisted shares completely free and more. Since this catastrophic emission failed (only 21 - 23 % was sold at full price - and only 34 % with a discount), the price of the old ordinary share, now that we know the dilution from the emission, should not be as low as 0.28 at all. The share - which had already fallen sharply - cost 0.63 SEK on the last trading day in November. With the dilution that has now occurred, where the emission was only completed by 57 %, the new price of the ordinary share (and the BTA) should theoretically immediately after the announcement rise to approx. 0.41 SEK, to correspond to the price before the emission. But things always go wrong with emissions in biotech - and this one showed from the start the epitome of incompetent management - unfortunately. But right now, you get all the shares for free if you pay 0.28 SEK, which roughly corresponds to the cash balance. Incredible - but true. And incredible that the main shareholder did not participate in the emission, but merely let their investment be diluted in this foolish way.2 päivää sitten2 päivää sittenThey have little chance to ever make profit on paper because the valuations on the balance sheet are astronomical, let alone finding anyone to buy any of the unlisted assets above the current valuations. You can't even value the cash at cash, because it's going to the investments, like you said, and the investment decisions are conducted by unbelievably incompetent people who are going to destroy capital as long as there is enough stupid people to further fund the company.·1 päivä sittenWith this premise " the investment decisions are conducted by unbelievably incompetent people who are going to destroy capital as long as there is enough stupid people to further fund the company." it is clear that you set the value of cash to 0 kr. in the long term. That is essentially also what I write in my analysis, namely that one must of course assess whether one believes in the company's management.
- ·28.1.The result of the issue may come tomorrow. The situation is unstable now and not all BTAs are out yet. It could go either way. BTA from subscription without TR is not finalized. Are there many of them? I note, however, that the turnover is relatively low compared to Medivir.
- ·27.1. · MuokattuNo matter how much this stock goes down, it always seems like there's 100 % left to go down...·28.1.That applies to all stocks, for that matter :)·28.1.The main owner seems not to have subscribed (at least not much, as a total of 21% was subscribed with subscription rights), so it will be very interesting to see the new ownership structure when the dust has settled after some guarantors' sell-off. Hope Anders Hallberg steps in significantly and sorts this out now.
- ·27.1.The underwriters have received a nice discount, since they are now selling 10% below the price we others have paid. There is currently a large hidden block BTA at a price of 2.7.·27.1.Yes, it seems IngvarS was right here. I interpret the trading in BTA to mean that guarantors have received allocation and then guess that the subscription rate will end up at the guarantee level and then KD gets in approx 100M and that makes a total of approx 650M shares (270+380) which gives a market cap of 175M at 0.27
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
100
Myynti
Määrä
9 494
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 93 | - | - | ||
| 5 | - | - | ||
| 2 | - | - | ||
| 7 970 | - | - | ||
| 3 717 | - | - |
Ylin
0,29VWAP
Alin
0,268VaihtoMäärä
0,5 1 925 610
VWAP
Ylin
0,29Alin
0,268VaihtoMäärä
0,5 1 925 610
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 925 610 | 1 925 610 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 925 610 | 1 925 610 | 0 | 0 |